Search filters

List of works by Ramon Colomer

18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

scientific article published in September 2016

3D Assessment of Lymph Nodes vs. RECIST 1.1.

scientific article published on 7 January 2011

A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms

scientific article

A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer

scientific article published on 01 May 2019

A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims

scientific article published on 01 May 2012

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

scientific article published on 16 December 2011

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

scientific article published on 14 December 2019

Advanced breast cancer clinical nursing curriculum: review and recommendations

scientific article published on 03 August 2016

Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors.

scientific article published on 2 May 2016

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

scientific article published on 21 December 2019

BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.

scientific article

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

scientific article published on 22 December 2017

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

scientific article published in February 2004

Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.

scientific article published on May 2003

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

scientific article

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

scientific article

Cancer care in rural areas.

scientific article published in April 2004

Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses ⬇️

scientific article published on March 15, 1992

Congress of the Spanish Society of Medical Oncology (SEOM) in Barcelona

scientific article published on 01 November 2009

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

scientific article published in September 2011

Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

scientific article published on 01 August 2018

Critically short telomeres and toxicity of chemotherapy in early breast cancer

scientific article

Current controversies in the management of early breast cancer.

scientific article published on June 2007

Dermatofibrosarcoma Protu-Berans with Lung Metastasis Requiring Pneumonectomy

scientific article

Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells

scientific article published on 01 November 2004

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease?

scientific article published on 01 December 2002

Dose and dose intensity effect of adjuvant anthracycline-based chemotherapy in early breast cancer: a retrospective analysis

scientific article published in June 2004

EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt

scientific article

Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.

scientific article published on November 2005

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

scientific article published on 01 November 2019

Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.

scientific article published on 28 September 2007

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.

scientific article published on 3 November 2014

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study

scientific article published on 17 December 2020

Giacomo Castelvetro's salads. Anti-HER2 oncogene nutraceuticals since the 17th century?

scientific article published on January 2008

High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: a confirmatory prospective study

scientific article published in November 2007

Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients

scientific article published on 22 January 2019

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.

scientific article published on 14 February 2013

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

scientific article published in Nature Communications

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

scientific article

Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.

scientific article published in January 2005

Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma

scientific article published in May 2004

Is Metastatic Disease the Best Setting for Cost-Effectiveness Studies?

scientific article published on 18 July 2016

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma ⬇️

scientific article published on January 1, 1997

Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells.

scientific article published on 17 February 2008

Management of metastatic breast cancer: are we prepared to cope with our own success?

scientific article published in December 2004

Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

scientific article published on 10 January 2017

Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.

scientific article

Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

scientific article published on 01 February 2019

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

scientific article published on 14 April 2016

New synthetic inhibitors of fatty acid synthase with anticancer activity

scientific article published on 16 May 2012

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

scientific article published on 24 May 2019

Nivolumab-induced thyroid dysfunction in patients with lung cancer

scientific article published on 15 June 2018

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

scientific article published on 01 December 2009

Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

scientific article published on October 2010

Obesity, fatty acid synthase, and cancer: serendipity or forgotten causal linkage?

scientific article published on 09 December 2004

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

scientific article published on February 2008

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer ⬇️

scientific article published on October 1, 1997

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety stu

scientific article published on 15 December 2017

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

scientific article published on 24 July 2014

Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.

scientific article published in January 2008

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

scientific article published on 01 March 2011

Prediction of response to targeted therapies in lung cancer using dynamic imaging: still far from clinical implementation.

scientific article published on 22 August 2011

Predictors of unknown cancer in patients with ischemic stroke.

scientific article

Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.

scientific article published on 19 December 2012

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.

scientific article

Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.

scientific article published on 26 March 2007

Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC.

scientific article published on 23 November 2017

Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis ⬇️

scientific article published on 01 June 1998

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization ⬇️

scientific article published on April 1, 1998

Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents

scientific article published on 08 June 2019

Selection of extreme phenotypes: the role of clinical observation in translational research.

scientific article

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial ⬇️

scientific article

Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome

scientific article published on 01 December 2018

Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.

scientific article

Strategies to design clinical studies to identify predictive biomarkers in cancer research.

scientific article published on 30 December 2016

Targeting cytoskeleton reorganisation as antimetastatic treatment.

scientific article published on October 2010

Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters.

scientific article published in April 2005

Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM).

scientific article published in March 2004

Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?

scientific article published in January 2005

[Complications of intramuscular metastasis in a patient with lung cancer]

scientific article published on 22 April 2010

[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology]

scientific article published on 14 March 2018

[Fatty acid synthase: a new anti-tumor target]

scientific article published on 09 March 2009

[Vaccines and breast cancer]

scientific article published on 01 November 2008

Paulina is supported by:

About Paulina

Help